Arena's Belviq sales continue up as others decline

22-02-2014 Seeking AlphaComments (0)

Arena PharmaceuticalsBelviq

Arena Pharmaceuticals (ARNA) continues to see sales of its anti-obesity drug, Belviq, rise in 2014, albeit more modestly than some would have hoped. The company is a week away from announcing Q4 results, and thus far the sales pace in Q1 is about 13% higher than Q4. 

Arena will offer up quarterly results on Thursday, February 27th at 5:00 pm Eastern. I have had a flurry of communications that the call was moved up by a week, but this is not really the case. I suspect that many investors were looking at websites that try


Read more on Seeking Alpha

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top